Langhorne, PA, United States of America

Wenting Chen




Average Co-Inventor Count = 6.1

ph-index = 12

Forward Citations = 1,209(Granted Patents)


Location History:

  • Exton, PA (US) (2003 - 2007)
  • Langhorne, PA (US) (2005 - 2007)
  • Beijing, CN (2010)

Company Filing History:


Years Active: 2003-2010

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: The Innovative Contributions of Wenting Chen in Pharmaceutical Sciences

Introduction

Wenting Chen is an accomplished inventor based in Langhorne, PA, with a remarkable portfolio of 15 patents. His work primarily focuses on the development of novel compounds that have significant implications for treating various medical conditions, particularly those related to serotonin receptor modulation.

Latest Patents

Among Wenting Chen’s latest contributions are two notable patents. The first patent, titled "Substituted Tricyclic Heterocycles as Serotonin Receptor Agonists and Antagonists," describes unique compounds and their pharmaceutical compositions useful in treating a variety of diseases. These diseases include metabolic disorders like obesity and diabetes, as well as central nervous system conditions such as anxiety, depression, and sleep disorders. The compounds, represented by Formula I, possess potential in addressing a broad range of health issues through modulation of serotonin receptors.

The second patent, "Substituted Heterocycle Fused Gamma-Carbolines," centers on compounds aimed at treating addictive behavior and sleep disorders. These compounds, described in structural Formula (I), function as serotonin agonists and antagonists, showing promise in the control and prevention of central nervous system disorders.

Career Highlights

Throughout his career, Wenting Chen has made substantial advancements in pharmaceutical research and development. His tenure at Bristol-Myers Squibb Pharma Company and Bristol-Myers Squibb Company has allowed him to refine his expertise in drug formulation and therapeutic strategies, contributing to the creation of effective treatments that target complex neurological and metabolic disorders.

Collaborations

Wenting has collaborated with prominent colleagues, including Taekyu Lee and Albert Jean Robichaud. Their teamwork has facilitated innovative research ventures and enhanced the potential impact of their findings in the realm of pharmaceuticals.

Conclusion

Wenting Chen’s innovative approach to developing serotonin receptor-targeting compounds underscores his commitment to advancing medical science. With a prolific patent portfolio and significant contributions to established pharmaceutical companies, Chen's work continues to pave the way for future breakthroughs in the treatment of various health disorders. Through collaboration and dedication, he exemplifies the spirit of innovation that drives the pharmaceutical industry forward.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…